Carlos Martín

5 June, 2024

Researcher Carlos Martín receives the Aragonese Prize of the Year

The professor leads the Mycobacteria Genetics team at the University of Zaragoza and the Aragon Health Research Institute (IIS Aragón), which develops the Aragonese vaccine against tuberculosis.
20 February, 2024

The Aragonese vaccine against tuberculosis could reach the market in 2027 or 2028

Designed by the University of Zaragoza, with the professor of Microbiology and researcher at the IIS Aragón Carlos Martín at the helm, and developed by the Galician biopharmaceutical company Biofabri.
October 3, 2023

Carlos Martín, microbiologist who develops the Spanish vaccine against tuberculosis: “We do not want to kill the bacteria, but rather train it”

The professor of microbiology and researcher at the IIS Aragón, leads the research that seeks a Spanish vaccine for tuberculosis (Mycobacterium tuberculosis).